Contact
William H. Frishman, M.D., is an internist and cardiologist with a research interest in cardiovascular pharmacology, clinical epidemiology, and geriatrics. Dr. Frishman has authored and co-authored more than 900 original articles, reviews, and book chapters. He has also edited, co-edited, authored, and co-authored twelve full-length textbooks, including the major text Cardiovascular Pharmacotherapeutics (McGraw-Hill), now in its second edition. Dr. Frishman published three books: Complementary and Integrative Therapies for Cardiovascular Disease (Elsevier 2005), Cardiovascular Regeneration and Stem Cell Therapy (Blackwell Futura, 2007), and Hypertension: A Clinical Guide (Lippincott, 2007). He is also the supplements editor for the American Journal of Medicine and a co-editor of the journal Cardiology in Review and the Yearbook of Medicine.
Education
- M.D., Boston University School of Medicine
Areas of Expertise
- Cardiovascular Pharmacology
- Clinical Epidemiology
- Geriatrics
Honors and Awards
- Teaching Scholar Award of the American Heart Association
- Preventative Cardiology Academic Award from the National Heart, Lung and Blood Institute
- Distinguished Teacher Award, Alpha Omega Alpha National Medical Honor Society
Research
Dr. Frishman has served as a principal investigator in multiple NIH-funded studies, including the "Systolic Hypertension in the Elderly" (SHEP) Trial, the "Studies of Left Ventricular Dysfunction" (SOLVD), the "Women's Health Initiative Trial" (WHI), and the "Bronx Longitudinal Aging Study."
Publications
- Singh NK, Weckerly ML, Abrahams RA, et. al. "Gene Editing in Cardiac Disease: A Review of the Literature." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000001143
- Seyam O, Frishman WH, Aronow WS, et. al. "Therapeutic Value of SGLT2 Inhibitors in the Management of Congestive Heart Failure." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000001154
- Mathukumar A, Go C, Frishman WH, et. al. "Underlying Aortopathies in Pregnancy: Early Detection, Management, and Advanced Planning." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000001089
- Pollock M, Frishman WH. "Pediatric Idiopathic Cardiomyopathy: Challenges in Etiology and Need for Targeted Therapy." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000001128
- Alkasabrah O, Ibrahim S, Hafeez A, et. al. "Bridging Cardiorenal and Hepatic Disease: The Emerging Role of SGLT2 Inhibitors in Cirrhosis." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000001141
- Gera P, Frishman WH, Aronow WS, et. al. "Atherosclerotic Cardiovascular Disease in South Asians: Epidemiology, Risk Factors, and Management." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000001144
- Abdullah M, Khalid N, Frishman WH, et. al. "Indications of Bempedoic Acid." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000001111
